On September 6, 2022, Pleco Therapeutics B.V. closed the transaction. The company received 4.6 million in the transaction. The company received 3.6 million in it's second and final tranche from new investor Oost NL BV and included participation from number of private investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.95 EUR | +2.14% | 0.00% | -6.27% |
Mar. 14 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
Mar. 14 | Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.27% | 358M | |
+25.61% | 660B | |
+25.87% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+7.09% | 219B | |
-9.12% | 196B | |
+5.01% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- HYL Stock
- News Hyloris Pharmaceuticals SA
- Pleco Therapeutics B.V. announced that it has received €4.6 million in funding from Hyloris Pharmaceuticals SA, Oost NL BV